Refex Pharma Services Private Limited
About Refex Pharma Services Private Limited
Data last updated:
Refex Pharma Services Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Anam Fine Chemicals Private Limited. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 31 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33119TN2021PTC142529.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Dinesh Kumar Agarwal and Patrik Vijay Kumar Francis Arun Kumar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.17 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹25.55 Lakh (net margin -356.3%) and EBITDA of ₹5.77 Lakh (EBITDA margin 80.5%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSecond Floor Refex Towers Sterling Road Signal, 313 Valluvar Kottam High Road Nungambakkam, Chennai, Tamil Nadu, India – 600034
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Refex Pharma Services Private Limited FY 2025 filings available
Refex Pharma Services Private Limited reported revenue of ₹7.17 Lakh (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Refex Pharma Services Private Limited
Revenue fell 2% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Refex Pharma Services Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.77 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹25.55 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Refex Pharma Services Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 80.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -356.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Refex Pharma Services are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Refex Pharma Services Private Limited
Refex Pharma Services Private Limited is audited by ABCD & Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ABCD & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Refex Pharma Services Private Limited
Refex Pharma Services has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Kumar Agarwal Also directs: Anam Medical Solutions Private Limited, Sourashakthi Energy Private Limited, Spangle Energy Private Limited and 5 more | Director | 31 Mar 2021 | 5 Years 6 Months | Current |
| Patrik Vijay Kumar Francis Arun Kumar Also directs: Anam Medical Solutions Private Limited, Refex Power Trading Private Limited, Engender Developers Private Limited and 5 more | Director | 05 Oct 2022 | 4 Years 0 Months | Current |
Ownership and Shareholding of Refex Pharma Services Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Refex Pharma Services Private Limited
Refex Pharma Services Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Refex Pharma Services Private Limited
Refex Pharma Services Private Limited has a workforce of 0 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Refex Pharma Services Private Limited
Refex Pharma Services Private Limited has 6 board changes on record since 2021: 4 appointments and 2 cessations. The latest: Chandresh Jain ceased to be Director on 10 Oct 2022.
Credit Ratings, Litigation & Regulatory Alerts for Refex Pharma Services Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Refex Pharma Services Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Refex Pharma Services Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Refex Pharma Services Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Refex Pharma Services Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Refex Pharma Services Private Limited
Refex Pharma Services is an active private limited company based in Chennai, Tamil Nadu, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 31 March 2021 (5+ years old) and is registered under CIN U33119TN2021PTC142529.
Refex Pharma Services reported revenue of ₹7.17 Lakh for FY 2025 (down 2% YoY).
Refex Pharma Services has 2 current directors:
- Dinesh Kumar Agarwal - Director
- Patrik Vijay Kumar Francis Arun Kumar - Director
Refex Pharma Services reported a net loss of ₹25.55 Lakh (net margin -356.3%) and EBITDA of ₹5.77 Lakh (EBITDA margin 80.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Refex Pharma Services is 6% over three years. In the latest year (FY 2025) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Refex Pharma Services is U33119TN2021PTC142529. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Refex Pharma Services was incorporated on 31 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
Chandresh Jain ceased to be Director on 10 Oct 2022. Patrik Vijay Kumar Francis Arun Kumar was appointed as Director on 05 Oct 2022. Anil Jain ceased to be Director on 28 Mar 2022. Refex Pharma Services has 6 board changes on record in total.
The registered office of Refex Pharma Services is at Second Floor Refex Towers Sterling Road Signal, 313 Valluvar Kottam High Road Nungambakkam, Chennai, Tamil Nadu, India – 600034.
Refex Pharma Services has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr.